Skip to content

Shares (Basic) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.1%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Solventum logo
SolventumSOLV
174.2M+0.3%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
163.9M-4.9%
Stryker logo
StrykerSYK
382.9M+0.3%
Medtronic logo
MedtronicMDT
1.3B-0.3%

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's shares (basic)?
Establishment Labs (ESTA) reported shares (basic) of 29.9M in Q1 2026.
How has Establishment Labs's shares (basic) changed year-over-year?
Establishment Labs's shares (basic) increased by 1.6% year-over-year, from 29.5M to 29.9M.
What is the long-term trend for Establishment Labs's shares (basic)?
Over 4 years (2021 to 2025), Establishment Labs's shares (basic) has grown at a 5.3% compound annual growth rate (CAGR), from 95.8M to 117.6M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.